Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 227 participants.

Also called NCT07747701

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 227 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07747701
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07747701. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-07-31 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring
Acronym
FACTOR
Condition
Acute Ischemic Stroke
Condition
Cerebral Autoregulation
Intervention (Device)
NIRS-based cerebral oxygenation and blood pressure monitoring
Intervention (Procedure)
Carotid compression test
Lead sponsor
Beijing Shijitan Hospital, Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct07747701
Content hash
a3b0407a7e39b3fcf9c94911f591cac0a2edba61c9a34c4e44125eb9a51116be